Table 2 Univariable analysis of transplant outcomes according to number of induction cycles.
Outcome | 1 | 2 | ≥ 3 |
|---|---|---|---|
Myeloid engraftment, CI at 30 days (%) | 96 (95–96) | 95 (92–97) | 95 (88–97) |
Platelet engraftment, CI at 60 days (%) | 94 (93–95) | 93 (89–95) | 93 (86–97) |
aGVHD grades II-IV, CI at 180 days (%) | 36 (34–39) | 31 (26–36) | 36 (27–45) |
aGVHD grades III-IV, CI at 180 days (%) | 13 (11–14) | 10 (7–14) | 12 (6–19) |
Overall cGVHD, 2-year CI (%) | 41 (38–43) | 40 (34–46) | 42 (31–52) |
Extensive cGVHD, 2-year CI (%) | 19 (17–21) | 17 (12–22) | 20 (12–29) |
NRM, 2-year CI (%) | 17 (15–19) | 18 (14–23) | 16 (9–24) |
RI, 2-year CI (%) | 23 (21–25) | 31 (26–37) | 32 (23–42) |
LFS, 2-year CI (%) | 60 (57–62) | 51 (45–57) | 52 (41–62) |
OS, 2-year CI (%) | 68 (66–70) | 61 (54–66) | 60 (49–70) |
GRFS, 2-year CI (%) | 41 (39–44) | 36 (30–42) | 36 (26–46) |
